Pharma External and Open Innovation 2010

Optimizing Drug Discovery, Research, and Development Through Strategic and Scientific External Innovation Networks.

As a means to remain profitable and gain a competitive edge, companies must establish relationships with external partners and harness open innovation as a key practice in the organization. Open and External innovation has provided an opportunity to gain knowledge and access to novel scientific breakthroughs and technology in various outlets. marcus evans Pharma External and Open Innovation 2010 conference will use expert practitioner experience and panel discussions in a classroom like setting to ensure that you walk away with a detailed account of how the biggest competitors in the pharmaceutical industry put open innovation into action throughout the different phases of drug discovery and development process. This conference is NOT ABOUT SIMPLY MANAGING A PROCESS; this conference is about assessing how your company looks at opportunity and how to turn opportunity into action!